Generation and Characterization of an Isogenic Cell Line Model of Radioresistant Esophageal Adenocarcinoma

Overview

Journal Methods Mol Biol

Specialty Molecular Biology

Date 2023 May 18

PMID 37202615

Authors

Aoife Cannon

Stephen G Maher

Niamh Lynam-Lennon

Affiliations

Soon will be listed here.

Abstract

Radiation therapy is a cornerstone of cancer treatment worldwide. Unfortunately, in many cases, it does not control tumor growth, and many tumors display treatment resistance. The molecular pathways leading to treatment resistance in cancer have been subject to research for many years. Isogenic cell lines with divergent radiosensitivities are an extremely useful tool to study the molecular mechanisms that underpin radioresistance in cancer research, as they reduce the genetic variation that is present in patient samples and cell lines of different origin, thus allowing the elucidation of molecular determinants of radioresponse. Here, we describe the process of generating an in vitro isogenic model of radioresistant esophageal adenocarcinoma by chronic irradiation of esophageal adenocarcinoma cells with clinically relevant doses of X-ray radiation. We also characterize cell cycle, apoptosis, reactive oxygen species (ROS) production, DNA damage and repair in this model to investigate the underlying molecular mechanisms of radioresistance in esophageal adenocarcinoma.

Citing Articles

Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study.

Nov P, Zheng C, Wang D, Sou S, Touch S, Kouy S Mol Med Rep. 2024; 30(6).

PMID: 39370813 PMC: 11450430. DOI: 10.3892/mmr.2024.13336.

References

Domina E, Philchenkov A, Dubrovska A . Individual Response to Ionizing Radiation and Personalized Radiotherapy. Crit Rev Oncog. 2018; 23(1-2):69-92. DOI: 10.1615/CritRevOncog.2018026308. View

Lynam-Lennon N, Reynolds J, Pidgeon G, Lysaght J, Marignol L, Maher S . Alterations in DNA repair efficiency are involved in the radioresistance of esophageal adenocarcinoma. Radiat Res. 2010; 174(6):703-11. DOI: 10.1667/RR2295.1. View

Fukuda K, Sakakura C, Miyagawa K, Kuriu Y, Kin S, Nakase Y . Differential gene expression profiles of radioresistant oesophageal cancer cell lines established by continuous fractionated irradiation. Br J Cancer. 2004; 91(8):1543-50. PMC: 2409931. DOI: 10.1038/sj.bjc.6602187. View

Wang L, Li S, Zhu X . Construction of Radiation Surviving/Resistant Lung Cancer Cell Lines with Equidifferent Gradient Dose Irradiation. Dose Response. 2021; 18(4):1559325820982421. PMC: 7758662. DOI: 10.1177/1559325820982421. View

Li Y, Li H, Peng W, He X, Huang M, Qiu D . DNA-dependent protein kinase catalytic subunit inhibitor reverses acquired radioresistance in lung adenocarcinoma by suppressing DNA repair. Mol Med Rep. 2015; 12(1):1328-34. DOI: 10.3892/mmr.2015.3505. View

McDermott N, Meunier A, Mooney B, Nortey G, Hernandez C, Hurley S . Fractionated radiation exposure amplifies the radioresistant nature of prostate cancer cells. Sci Rep. 2016; 6:34796. PMC: 5050515. DOI: 10.1038/srep34796. View

Franken N, Rodermond H, Stap J, Haveman J, van Bree C . Clonogenic assay of cells in vitro. Nat Protoc. 2007; 1(5):2315-9. DOI: 10.1038/nprot.2006.339. View

Pawlik T, Keyomarsi K . Role of cell cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol Biol Phys. 2004; 59(4):928-42. DOI: 10.1016/j.ijrobp.2004.03.005. View

Brown J, Attardi L . The role of apoptosis in cancer development and treatment response. Nat Rev Cancer. 2005; 5(3):231-7. DOI: 10.1038/nrc1560. View

10.

Meyn R, Stephens L, Milas L . Programmed cell death and radioresistance. Cancer Metastasis Rev. 1996; 15(1):119-31. DOI: 10.1007/BF00049491. View

11.

Diehn M, Cho R, Lobo N, Kalisky T, Dorie M, Kulp A . Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature. 2009; 458(7239):780-3. PMC: 2778612. DOI: 10.1038/nature07733. View

12.

Taneja N, Davis M, Choy J, Beckett M, Singh R, Kron S . Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem. 2003; 279(3):2273-80. DOI: 10.1074/jbc.M310030200. View

13.

Kuwahara Y, Li L, Baba T, Nakagawa H, Shimura T, Yamamoto Y . Clinically relevant radioresistant cells efficiently repair DNA double-strand breaks induced by X-rays. Cancer Sci. 2009; 100(4):747-52. PMC: 11158180. DOI: 10.1111/j.1349-7006.2009.01082.x. View

14.

Darzynkiewicz Z, Juan G, Li X, Gorczyca W, Murakami T, Traganos F . Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry. 1997; 27(1):1-20. View

15.

Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C . A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J Immunol Methods. 1995; 184(1):39-51. DOI: 10.1016/0022-1759(95)00072-i. View

16.

Radford I . The level of induced DNA double-strand breakage correlates with cell killing after X-irradiation. Int J Radiat Biol Relat Stud Phys Chem Med. 1985; 48(1):45-54. DOI: 10.1080/09553008514551051. View

17.

Fernandez-Capetillo O, Chen H, Celeste A, Ward I, Romanienko P, Morales J . DNA damage-induced G2-M checkpoint activation by histone H2AX and 53BP1. Nat Cell Biol. 2002; 4(12):993-7. DOI: 10.1038/ncb884. View

18.

Banath J, Klokov D, MacPhail S, Banuelos C, Olive P . Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer. 2010; 10:4. PMC: 2819996. DOI: 10.1186/1471-2407-10-4. View